Detalles de la búsqueda
1.
Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis.
Hum Mol Genet
; 31(13): 2155-2163, 2022 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35088080
2.
Technical challenges for complete implementation of automated growth-based methods for microbiological examination of advanced therapy medicinal products. What's wrong with Candida albicans?
Cytotherapy
; 24(3): 320-333, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35033424
3.
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease.
PLoS Genet
; 15(6): e1008180, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31170158
4.
Treatment of faecal incontinence with autologous expanded mesenchymal stem cells: results of a pilot study.
Colorectal Dis
; 23(3): 698-709, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32986295
5.
Mesenchymal Stem Cells From Adipose Tissue Do not Improve Functional Recovery After Ischemic Stroke in Hypertensive Rats.
Stroke
; 51(1): 342-346, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31694504
6.
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis.
Hum Mol Genet
; 24(19): 5619-27, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26152201
7.
Decreased soluble IFN-ß receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.
Mult Scler
; 23(7): 937-945, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27613121
8.
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.
Ann Neurol
; 77(3): 447-57, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25581547
9.
Cell-based product classification procedure: What can be done differently to improve decisions on borderline products?
Cytotherapy
; 18(7): 809-15, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27209278
10.
TRAIL and TRAIL receptors splice variants during long-term interferon ß treatment of patients with multiple sclerosis: evaluation as biomarkers for therapeutic response.
J Neurol Neurosurg Psychiatry
; 87(2): 130-7, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25736057
11.
Genome-wide significant association with seven novel multiple sclerosis risk loci.
J Med Genet
; 52(12): 848-55, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26475045
12.
A new risk variant for multiple sclerosis at the immunoglobulin heavy chain locus associates with intrathecal IgG, IgM index and oligoclonal bands.
Mult Scler
; 21(9): 1104-11, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25392328
13.
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-ß therapy in multiple sclerosis.
J Med Genet
; 51(6): 395-400, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24748646
14.
Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis.
J Med Genet
; 50(1): 25-33, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23160276
15.
Autologous stem cells for the treatment of post-mastectomy lymphedema: a pilot study.
Cytotherapy
; 13(10): 1249-55, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21999374
16.
Kinetics and incidence of anti-natalizumab antibodies in multiple sclerosis patients on treatment for 18 months.
Mult Scler
; 17(3): 368-71, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21177326
17.
The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study.
Mult Scler
; 17(2): 192-7, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21088044
18.
Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis Pathogenesis.
Mol Neurobiol
; 58(2): 470-482, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32974731
19.
Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment.
Front Immunol
; 12: 778204, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34975865
20.
Skin Phototype Could Be a Risk Factor for Multiple Sclerosis.
J Clin Med
; 9(8)2020 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32722577